motilis
Motilis is a brand name for a medication used to treat irritable bowel syndrome (IBS) with constipation. It is a proprietary formulation of the drug linaclotide, which belongs to a class of drugs known as guanylate cyclase-C (GC-C) agonists. Linaclotide works by stimulating the production of nitric oxide in the gut, which helps to relax the muscles in the intestines and increase the movement of stool through the digestive system.
Motilis is available in the form of a liquid suspension for oral administration. It is typically taken
The most common side effects of motilis include abdominal pain, diarrhea, and nausea. These side effects are
Motilis was approved by the U.S. Food and Drug Administration (FDA) in 2010 and by the European